Cystinosis is a rare autosomal recessive disorder caused by mutations in CTNS gene, encoding for the lysosomal cystine proton cotransporter cystinosin. 1 It is characterized by the lysosomal accumulation of cystine, which leads to the formation of cystine crystals within various organs, including kidneys, brain, cornea, intestine, and bone marrow. 2 The exact role of intralysosomal crystal accumulation in the pathogenesis of cystinosis remains unclear. On the basis of the increasing body of evidence demonstrating the role of host-derived crystalline moieties (associated with danger, damage, or cell death) in inflammasome activation, 3 we have investigated whether cystine crystals are able to elicit an inflammatory response via inflammasome activation.
Inflammasomes are a group of intracellular protein complexes that recognize a diverse set of inflammationinducing stimuli (pathogen-associated molecular patterns and damage-associated molecular patterns) and control the caspase-1-dependent proteolytic maturation and release of the proinflammatory cytokines IL-1b and IL-18. 4, 5 The NLRP3 inflammasome is the best characterized inflammasome, formed by the adaptor protein ASC, pro-caspase-1, and NLRP3. 6 NLRP3 is activated by endogenous crystals or particle formats, including monosodium urate, calcium phosphate, hydroxyapatite, silica, asbestos, and cholesterol crystals. [7] [8] [9] [10] [11] [12] Although the exact mechanism by which NLRP3 is activated is still unknown, NLRP3 activation by crystalline structures has been demonstrated to require phagolysosomal destabilization, generation of reactive oxygen species (ROS), and potassium efflux. 13 To understand whether the inflammasome is activated by cystine crystals, we investigated whether cystine crystals induce IL-1b secretion from cultured PBMCs. For this purpose, cystine crystals were added to LPS-primed PBMCs and incubated for 6 hours. As shown in Figure 1A , addition of cystine crystals induced dose-dependent IL-1b secretion, similarly to crystals of monosodium urate (positive control). 9 Treatment of PBMCs with cystine crystals alone, in the absence of LPS priming, did not result in detectable IL-1b production (not shown), excluding the possibility of microbial contaminations in these crystal preparations. Western blotting of cell culture supernatants confirmed that cystine crystals induced mature IL-1b secretion and CASP-1 activation, as demonstrated by the presence of the mature cleaved form of IL-1b and activated caspase-1 in the supernatants of cystine crystal-stimulated cells ( Figure  1A , bottom).
Because crystalline inflammasome activators need to be phagocytized by phagocytes to elicit IL-1b secretion, 7, 12 we used confocal reflection microscopy to explore whether cystine crystals were internalized by mononuclear adherent cells. Cell membranes were stained with anti-heat germ agglutinin antibodies. Small hexagonal or rectangular cystine crystals were found in LPSprimed cells ( Figure 1B ) and in unstimulated cells (not shown), enveloped by the plasma membrane.
To confirm the role of inflammasome activation in cystine crystal-induced IL1b secretion, we used z-YVAD-fmk, a specific caspase-1 inhibitor. IL-1b production decreased markedly ( Figure  2A ), confirming the involvement of an inflammasome-mediated pathway. We then examined whether the phagocytic function of mononuclear cells was required for cystine crystal-induced activation of inflammasome. Inhibition of actin polymerization with cytochalasin D effectively blocked cystine crystalinduced IL-1b secretion ( Figure 2A ) but did not affect ATP-induced IL-1b production (not shown). On the basis of the evidence that lysosomal destabilization and ROS production are involved in NLRP3 inflammasome activation, 14 pretreatment of PBMCs with the cathepsin B inhibitor CA-074Me and diphenyleneiodonium chloride, a chemical inhibitor of ROS production, were performed. As showed in Figure 2B , both inhibitors abrogated the secretion of IL-1b induced by cystine crystals. Furthermore, we assessed the requirement of potassium efflux in cystine crystalinduced inflammasome activation by incubating human PBMCs with high extracellular KCl concentration. IL-1b secretion was completely inhibited when potassium efflux was prevented ( Figure 2B ). Together these data indicate that the stimulatory effect of cystine crystals on IL-1b production depended on cathepsin B leakage, ROS production, Figure 1 . Cystine crystals induce IL-1b secretion in LPS-primed human PBMCs and are internalized by monocytes in vitro. (A) Primary human PBMCs were primed with LPS (100 ng/ml) for 2 hours and then incubated with increasing concentration of cystine crystals or monosodium urate crystals (MSU) for 6 hours. Supernatants were collected and IL-1b was measured by ELISA. Data are representative of three independent experiments performed in duplicate and are expressed as means6SD (top). Supernatants (SN) were also analyzed by Western blotting using antibodies detecting the mature form of IL-1b and the activated caspase-1 form (bottom). (B) Monocytes isolated by adherence from freshly isolated PBMCs were prestimulated with LPS (100 ng/ml) for 2 hours and then incubated with cystine crystals for 6 hours. At the end of incubation, cells were stained with anti-wheat germ agglutinin (WGA) lectin (green) to label plasma cell membranes and Hoechst stain (blue) to label nuclei. Cells were imaged by confocal fluorescent microscopy. and K + efflux, similarly to known crystalline inflammasome activators. 12 Having demonstrated the effect of cystine crystals on inflammasome activation by in vitro studies, we focused on the physiopathologic relevance of our findings. To this end, we investigated patients with cystinosis and Ctns 2/2 mice. First, we measured IL-1b and IL-18 levels in plasma collected from patients with cystinosis. Levels of both circulating IL-1b and IL-18 were significantly higher in patients than controls (P=0.05 and P,0.0001, respectively) ( Figure 3 , A and B). When cystinotic patients were compared with patients with familial Mediterranean fever, a known genetic autoinflammatory disorder characterized by inflammasome deregulation, 15 circulating IL-1b levels were similar in the two cohorts of patients, while IL-18 levels were significantly higher in cystinotic patients than in those with FMF (P=0.002). Moreover, IL-1b transcript levels were significantly increased (P=0.0003) in PBMCs isolated from cystinotic patients ( Figure 3C ) compared with controls. Interestingly, we observed a positive correlation between intracellular cystine levels at the time of blood sampling and IL-1b mRNA expression in freshly isolated PBMCs (Spearman r=0.645; P=0.03) ( Figure  3D ). In addition, we found a significant increase (P=0.03) in CASP-1 mRNA expression in cystinotic patients compared with controls ( Figure 3E ) but no differences in NLRP3 or TNF-a (a gene whose expression is unrelated to inflammasome activation) expression (Figure 3 , F and G). Circulating IL-1b levels were higher in pretransplant patients than in patients who had undergone transplantation; circulating IL-18 levels were significantly higher both in pretransplant patients and transplant recipients than in controls (Supplemental Figure 1 , A and B). Although we did not observe a significant correlation between patients' GFR and IL-1b levels (r=2 0.07; P=0.82), we found a trend for a negative correlation between GFR and IL-18 levels (r=20.52; P=0.08). Age and IL-1b levels were correlated (r=20.67; P=0.03); age and IL-18 levels were not (r=20.18; P=0.57). We have no clear explanation for this observation, which is apparently not related to whether the patient has undergone transplantation or not. Of note, no correlations between age and both IL-1b and IL-18 levels were observed in our cohort of controls. Of notice, all patients were treated with cysteamine, which depletes intracellular cystine content.
Finally, to support our results obtained in humans, we investigated the activation of the inflammasome in the mouse model of nephrophatic cystinosis, 16 the Ctns 2 /2 mouse, by performing a gene expression profiling on kidney, spleen, liver, and muscle tissues from 16-month-old mice. In kidneys, but not in the other tissues analyzed, we observed a significant upregulation of some of the genes involved in the inflammasome activation pathway, including Casp1, Pycard (Asc), Il18, Il18r1, Il1r1, and Il1rl2 in Ctns 2/2 mice compared with wild-type (WT) mice ( Figure 4A ). We confirmed these data by real time PCR on another group of Figure 2 . Cystine crystal-induced IL-1b secretion requires caspase-1 activation, actin polymerization, lysosomal protease activity, ROS generation, and potassium efflux. PBMCs were primed with LPS (100 ng/ml) for 2 hours, incubated for 30 minutes in the presence or absence of (A) the CASP-1 inhibitor z-YVAD-fmk (5 mM) or phagocytosis inhibitor cytochalasin D (5 mM) or (B) cathepsin B inhibitor CA-074Me (10 mM) or diphenyleneiodonium chloride (DPI) (20 mM) or 130mM KCl. Cystine crystals or monosodium urate crystals (MSU) were added for 6 hours. Supernatants were collected and IL-1b was measured by ELISA. Data are representative of three independent experiments performed in duplicate and are expressed as means6SD. *P,0.05 compared with cells stimulated in the absence of inhibitors.
15-/17-month-old mice (Figure 4, B-D) . To verify whether the inflammasome pathway was also upregulated in an early phase of the disease, we analyzed Il18, Casp1, and Pycard gene kidney expression in 5-/7-month-old mice. The expression of these genes was significantly upregulated even in the younger Ctns 2/2 mice compared with WT mice (Figure 4 , B-D). We measured IL-1b and Il-18 levels in sera collected from 5-/7-or 15-/17-month-old Ctns 2/2 mice and compared them with those of age-matched WTmice. Serum IL-18 levels were significantly higher in both groups of Ctns 2/2 mice compared with WT mice (Figure 4E ), while IL-1b was not detectable in the mice tested.
In this study, we have shown that phagocytized cystine crystals can elicit an inflammatory reaction by triggering IL-1b secretion by inflammatory cells, demonstrating that they represent an endogenous danger signal sensed by inflammasomes. Intralysosomal accumulation of cystine in tissues is the hallmark of cystinosis, but the exact role played by these crystals in the pathogenesis of the disease is still a matter of debate. Our data suggest that cystine crystals may not be inert but rather a trigger of inflammation, as recently demonstrated for calcium oxalate crystals in nephrocalcinosis. 17 Elevated circulating levels of IL-1b and IL-18 in cystinotic patients and elevated inflammasome-related gene expression both in PBMCs from patients and in kidney tissue from Ctns 2/2 mice support the hy pothesis that inflammasome activation may contribute to the development of the interstitial inflammation and fibrosis leading to ESRD observed in cystinotic patients and mice. Interestingly, the inflammasome-regulated cytokines IL-1b and IL-18 are implicated in several animal models or human forms of CKD. [18] [19] [20] In this study, we used LPS to prime the inflammasome because the nature of the immunostimulatory priming signals in cystinosis are unknown. Indeed, on the basis of the evidence that pattern recognition receptors can also be activated by host-derived nonmicrobial stimuli (i.e., sterile inflammation), 21 we hypothesize that, in vivo, the priming of the inflammasome can be provided by endogenous molecules that are released during cellular injury (especially in kidneys) and inflammasome activation is triggered by cystine crystals.
Which cells express functional inflammasomes in the kidney is largely unknown. Several studies demonstrated that proximal tubular epithelial cells (PTECs) and mesangial cells are involved in the release of chemokines, such as monocyte chemotactic protein-1, and cytokines, such as IL-6, TNF, and IL-1b 22 ; hence, they should express all necessary components of the inflammasome caspase-1/IL-1b/IL-18 axis.
On the basis of this evidence and on our results, we propose a speculative model in which lysosomal cystine crystal accumulation, acting as a "stress signal," induces lysosomal leakage, mitochondrial oxidation stress, and possibly inflammasome activation in PTECs. In turn, PTECs produce higher amounts of proinflammatory cytokines and chemokines, which subsequently promote infiltration of inflammatory cells. Eventually, extracellular minute cystine crystals and intracellular cystine crystals trigger activation of inflammasome also in infiltrating inflammatory cells (macrophages and dendritic cells). Notably, cystine crystals were observed in interstitial cells and macrophages of most organs, particularly in kidneys, of Ctns 2/2 mice and of cystinotic individuals. 16, 23 Consistent with this observation, we found significant upregulation of inflammasome-related genes in kidneys of Ctns 2/2 mice. Compared with other forms of Fanconi syndrome associated with low-molecularweight protein urinary excretion, such as Lowe syndrome and Dent disease, cystinosis is characterized by a more rapid progression to ESRD. Biopsies show progressive interstitial fibrosis and development of swan-neck tubular strictures, which are believed to be due to early apoptotic events of tubular cells in the S1 segment. It may well be that inflammation caused by cystine crystals is responsible for these early changes; positive effects on renal function of cysteamine, 24 which depletes intralysosomal cystine content, would support this hypothesis. According to our findings, therapeutic strategies that dampen cystine crystaltriggered inflammasome activation may complement conventional therapies used in cystinosis treatment.
CONCISE METHODS

Preparation of L-Cystine Crystals
The hexagonal form was crystallized from a supersaturated solution prepared by adding 70 mg of L-cystine to 100 ml of deionized water and heating under reflux at 100°C for 20 minutes with stirring, as described by Rimmer et al. 25 The crystals were collected and evaporated to dryness using a vacuum concentrator, autoclaved, and stored at 220°C until use.
Human Cell Culture
PBMCs were obtained from buffy coats of healthy donors after centrifugation over FicollHystopaque (Pharmacia, Uppsala, Sweden) gradients as described. Freshly isolated PBMCs were suspended in RPMI 1640 (Gibco) supplemented with 10% human serum, seeded in 96-well plates at a density of 5.0310 5 cells/well and incubated overnight at 37°C. The next day, PBMCs were stimulated with 100 ng/ml LPS (Escherichia coli serotype 055:B5; Sigma-Aldrich) for 2 hours, followed by incubation with cystine crystals or MSU (Alexis Biochemicals, San Diego, CA) for 6 hours. In some experiments, cells were preincubated 30 minutes before crystal addition with the caspase-1 inhibitor z-YVAD-fmk (Alexis Biochemicals), cytochalasin D (Sigma-Aldrich), cathepsin B inhibitor CA-074Me (Calbiochem), diphenyleneiodonium chloride (ENZO Life Sciences), or 130 mM KCl.
Confocal Reflection Microscopy
PBMCs were incubated overnight at 37°C. The next day, nonadherent cells were removed and mononuclear adherent cells were incubated with 100 ng/ml LPS for 2 hours, followed by incubation with cystine crystals for 6 hours. At the end of incubation, cells were fixed for 20 minutes in 4% paraformaldehyde in PBS and immunostained for wheat germ agglutinin. The nuclei were stained with Hoechst stain. Confocal images were acquired using the Olympus Fluoview FV1000 confocal microscope equipped with FV10-ASW version 2.0 software.
ELISA and Western Blotting
After stimulation, cell culture media were collected and human IL-1b was measured using commercial ELISA kits (R&D Systems, Minneapolis, MN). The assays were performed according to the manufacturer's instructions. The detection limit of the assay was 7.8 pg/ml. Human and mouse circulating IL-1b and IL-18 levels were measured using human IL1b/IL-1F2 Quantikine HS ELISA Kit (R&D Systems) and human or mouse IL-18 ELISA kit (Medical and Biologic Laboratories, Nagoya, Japan), according to the manufacturer's instructions. The detection limits for these assays were 0.023 pg/ml, 25 pg/ml, and 25.6 pg/ml, respectively.
For Western blotting, cell culture supernatant proteins were resolved by 15% SDS-PAGE. Proteins were then transferred to nitrocellulose membranes (Amersham Life Sciences, Little Chalfont, UK), and probed with polyclonal rabbit antibody to human IL-1b and caspase-1 (Cell Signaling Technology, Beverly, MA) using standard procedures.
RNA Isolation and Quantitative Real-Time PCR
Total RNA was extracted from 13 10 6 PBMCs or mouse kidney tissues using QiagenRNeasy Mini kit (Qiagen, Valencia, CA), and cDNA was obtained using the Superscript Vilo kit (Invitrogen). Real-time PCR assays were performed using TaqMan Universal PCR Master mix (Applied Biosystems) and the following gene expression assays: human IL-1b, CASP-1, NLRP3, PYCARD (ASC ), TNF-a (Applied Biosystem) and mouse Casp1, Pycard (Asc) and Il18. Gene expression data were normalized using human or mouse GAPDH (Applied Biosystems) as endogenous controls. Data are expressed as arbitrary units (AU), determined using the 2 2Δct method.
Intracellular Cystine Measurement
HPLC with fluorescence detection assay on polymorphonuclear leukocytes isolated from cystinotic patients has been performed. 26 The double-stranded biotinylated cDNA from each tissue for each mouse was run on individual Affymetrix GeneChip. The data were collected as CEL files, and quality control analysis was performed with Affymetrix Expression Console. Normalized signal intensities were generated with Robust Multichip Average, which uses a background adjustment and quantile normalization strategy. 27 Genes without an average log 2 -transformed signal above 6 in the WT or Ctns 2/2 group were removed from further analysis. Class comparisons of variance by two-way t tests for two-sample comparisons (P,0.001) were performed using BRBArrayTools (http://linus.nci.nih.gov/BRBArrayTools.html) to identify the set of significantly differentially expressed genes between WT and Ctns 2/2 mice in each tissue. years]). Cystinosis had been diagnosed between ages 9 months and 4 years; in all patients the diagnosis was based on the demonstration of elevated cystine levels in leukocytes and on the demonstration of homozygous or compound heterozygous mutations of the CTNS gene. All patients were treated with cysteamine bitartrate. At the time of blood sample collection, no patient had evidence of infection or inflammation, and none had increased C-reactive protein.
Gene Expression Microarray Analysis
Similarly, all the patients with FMF (n=23; median age, 10.0 years [IQR, 9-13 years]) were in a symptom-free period and were receiving colchicine treatment at the time of blood collection. Patients hospitalized for planned minor surgical procedures with an age similar to that of pretransplant cystinotic patients (n=27; median age, 9.0 years [IQR, 6-13 years]; P.0.5) were used as controls. Blood samples were collected before surgery. The patients did not have evidence of infection or inflammation or increased C-reactive protein at the time of sample collection. All blood samples were taken after patients provided informed consent. Institutional Ethical Committee approved the study.
Statistical Analyses
Data are presented as means6SDs or as median and IQRs. We performed group comparisons using the nonparametric Mann-Whitney U test. To assess the correlations between variables, we calculated the Spearman rank correlation coefficient (r). All statistical analyses were performed using GraphPad Prism IV software. P,0.05 was considered to represent statistically significant differences.
